S

Sorrento Therapeutics, Inc.

415 employees

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Investor insights

Sectors invested in

Biotechnology3
Therapeutics3
Health Care3
Wellness2
Health Diagnostics1

Funding rounds participated in

$45M sweet spot round size

Most of their 4 investments are in rounds between $4M and $80M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
cancer
Diagnostics
COVID-19
infectious diseases
Biopharma
Non-opioid pain management
Medical
Health Care

Date founded

2009

Investments made

C

Celularity, Inc. raised $80M on July 19, 2021

Investors: Sorrento Therapeutics, Inc.

C

Celularity, Inc. raised $250M on February 15, 2018

Investors: Section 32, United Therapeutics Corporation, Human Longevity, Inc., Heritage Group, Celgene and Sorrento Therapeutics, Inc.

G

Globavir Biosciences, Inc. raised $4M on January 31, 2015

Investors: Sorrento Therapeutics, Inc.

U

Undisclosed raised $10M on January 1, 2015

Investors: NantWorks LLC and Sorrento Therapeutics, Inc.

FAQ